Unregulated US Clinics Market Unproven Stem Cell Longevity Treatments
Source Summary
An FT investigation has identified a thriving market for stem cell therapies in the US that claim to extend life and improve health. Experts warn that such unproven claims pose dangers to patients seeking these treatments.
Why it matters
Unproven stem cell treatments marketed for longevity pose direct health risks to patients and represent a regulatory gap in medical oversight.
